Diazoxide

Product manufactured by E5 Pharma, Llc

Application Nr Approved Date Route Status External Links
ANDA211050 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Diazoxide Oral Suspension, Usp Is Useful In The Management Of Hypoglycemia Due To Hyperinsulinism Associated With The Following Conditions: Adults: Inoperable Islet Cell Adenoma Or Carcinoma, Or Extrapancreatic Malignancy. Infants And Children: Leucine Sensitivity, Islet Cell Hyperplasia, Nesidioblastosis, Extrapancreatic Malignancy, Islet Cell Adenoma, Or Adenomatosis. Diazoxide Oral Suspension, Usp May Be Used Preoperatively As A Temporary Measure, And Postoperatively, If Hypoglycemia Persists. Diazoxide Should Be Used Only After A Diagnosis Of Hypoglycemia Due To One Of The Above Conditions Has Been Definitely Established. When Other Specific Medical Therapy Or Surgical Management Either Has Been Unsuccessful Or Is Not Feasible, Treatment With Diazoxide Should Be Considered.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diazoxide DIAZOXIDE ZINC3872277

Comments